Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (321-330 of 391) with videos related to

Pageof 40
Sort By:
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2025
Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative diseaseKaleigh F Roberts, Eric C Landsness, Justin Reese, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
The global Alzheimer's Association round robin study on plasma amyloid β methodsJosef Pannee, Leslie M Shaw, Magdalena Korecka, et al.
Pageof 40

Showing results (321-330 of 391) with videos related to

Sort By:
Pageof 40
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2025
Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative diseaseKaleigh F Roberts, Eric C Landsness, Justin Reese, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
The global Alzheimer's Association round robin study on plasma amyloid β methodsJosef Pannee, Leslie M Shaw, Magdalena Korecka, et al.
Pageof 40